FDA Division of Biology, Chemistry, and Materials Science
WHAT: Part of Office of Science and Engineering Laboratories (OSEL), CDRH
WHY:
- Determine effects of implanted devices, potential device adverse effects, source and impact of device degradation
- Develop experimental data, test methods, and protocols
- Develop measurements, methods, and analytical procedures to support CDRH pre-market and post-market activities.
WHO: Experts in biology, biomaterials science, biomedical and chemical engineering, chemical physics, materials science, pharmacology, physical chemistry, polymer science, and toxicology
HOW: Focus on
- analytical chemistry and electrochemistry
- biocompatibility, toxicology, and biological risk assessment
- biosensors and biomarkers
- extractables, leachables, and chemical contamination
- genomic and genetic technologies
- immune and cellular responses
- infection control, sterility, and biofilms
- materials characterization, processing, and materials degradation
- modeling of physiological processes
- multicomponent mass transfer and reaction kinetics
- nanotechnology